A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases. - Wikidata - wikimedia - TriplyDB

A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.

A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.

http://www.wikidata.org/entity/Q37317390

about

Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.Role of Natural Killer Cells in HIV-Associated Malignancies.Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an "Off-the-Shelf Immunotherapy" for Improvement in Cancer Treatment.The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.CAR T-cell therapy of solid tumors.Engineering Natural Killer Cells for Cancer Immunotherapy.Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model.The Broad Spectrum of Human Natural Killer Cell Diversity.Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy.Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma.NK-92 cell, another ideal carrier for chimeric antigen receptor.Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.Tumor immunotherapy: New aspects of natural killer cells.Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies

P2860

Q28079180-4C294259-FB17-47CC-ACD5-BAB3ABBF0EE1 Q33700795-2A306B6E-9C7B-479E-A8AC-4835CD50AFC4 Q33913839-941316E9-A1DA-496A-BA40-342F0C108282 Q37609801-9BC3FC13-5478-40C3-ABFB-0447F832F1E1 Q37712593-0F16DC01-FB4B-4927-BB1E-3C7BE1644489 Q38666862-D67F0525-317B-4854-A787-E67CAB1A0B6E Q38670431-33A63A15-C26A-45AD-A795-F751660FD13B Q38685785-75B9A915-92DF-430F-AF3C-4532DCCC503F Q38694652-C7670B0F-8F01-4D74-8CE1-7F44336D50C7 Q39047856-B1F1E04A-2A8F-4342-90E2-78E40C4143F7 Q39408704-9050DDDF-67A8-4B05-85C1-86069CAEBB82 Q41074467-9D8347EF-9A8E-4109-BDFD-545C69ACBEEE Q47373461-D7DC7832-92C0-43F6-99A9-C15A8D963563 Q47843897-46DABA67-D8D9-4DBF-8466-31F0269A17C0 Q48504970-CC7B7445-96A6-4C5A-9B4A-C77BF6D0893C Q50027824-EEE41666-5ABE-4727-97BF-66F0C992536E Q53705286-1B3A4F4C-0CC5-463D-BE29-356627D48300 Q55107050-F1B5A94B-205A-46EA-A931-4084C9347259 Q57300237-B226F02C-3405-422F-A5A2-09F4A3295119

P2860

A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.

http://www.wikidata.org/entity/Q37317390

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A combinational therapy of EGF ...... reast cancer brain metastases.

@en

A combinational therapy of EGF ...... reast cancer brain metastases.

@nl

type

label

A combinational therapy of EGF ...... reast cancer brain metastases.

@en

A combinational therapy of EGF ...... reast cancer brain metastases.

@nl

prefLabel

A combinational therapy of EGF ...... reast cancer brain metastases.

@en

A combinational therapy of EGF ...... reast cancer brain metastases.

@nl

P1433

Q37317390-A7FB7C3C-CBD8-4E07-9864-DA68F3A159AF

P1476

Q37317390-7203EC82-C0B8-407B-B67B-C3EC0788A3D2

P2093

Q37317390-0100A1B0-0352-4E2E-A017-2CF0EC03FA05

Q37317390-075051AF-2746-44A7-AACF-77BC3D7D179B

Q37317390-202E0BF8-FBB6-48A6-9EAA-5D26232873B5

Q37317390-3C4AA45B-B5F7-4313-9872-7C58D31760C7

Q37317390-4020BFD1-2000-4670-BB78-45C4C63FABE9

Q37317390-724553A3-09E9-4B28-834C-D7628401053B

Q37317390-8B19ED6B-84B0-4560-9147-9E5A0F7FD88C

Q37317390-8D08CF92-5582-4D9F-8780-6344BDE495E3

Q37317390-A66EA7FE-AF61-4F83-9577-CABCF4B1D2E8

Q37317390-C5C4A1F6-2114-4DEA-98CB-1337E7C99DF4

P2860

Q37317390-0A2E6B54-BCCA-4DAF-AE21-CBB473611C7C

Q37317390-0A9D6825-79BB-439A-8B23-F14ACF3D6AA7

Q37317390-194AFCD0-79AB-4573-A7EB-008BDD4E243C

Q37317390-208464A9-2FD3-46C8-9116-DC14EF164BC3

Q37317390-231F757C-23E7-428A-8F43-0E8EBAC2C651

Q37317390-245DF3F8-0AEC-4137-AFA0-0E797F08E1A4

Q37317390-257FBFE4-73B4-4D8F-9CB9-9395963DD734

Q37317390-2BB5D2D1-4AE4-4AB6-9347-317FB2B7207C

Q37317390-2FDE4F81-7D7D-4460-8475-D3FE55D4761D

Q37317390-3A806CC6-F1DB-4530-BBF9-7D640802979B

P304

Q37317390-0EA0E22B-EDD3-4B98-9BD9-41C7FE7C2F61

P31

Q37317390-98CF37AF-C21E-4B09-88E3-6FB90FE7B05A

P356

Q37317390-BD48F42C-BDFA-4C44-B71C-F31E31B8E6A8

P407

Q37317390-1950032D-666C-4C26-99DD-E3CA863C6B13

P433

Q37317390-025A4740-16B9-45EE-A0ED-7F757AB5C55C

P478

Q37317390-6F21E6D6-4DC0-4595-9717-528674FFB9CE

P50

Q37317390-99FFA896-394B-4DAF-8A1F-576EA784D143

P577

Q37317390-0DFBC002-66A0-44DB-952D-C6A1538E47B1

P698

Q37317390-C4A6AE7A-0BBC-4CFC-A477-17C0FD5F7522

P921

Q37317390-F80172D3-B75E-43BC-A3A3-64BAB58DCAFA

P932

Q37317390-C9BCA157-8717-47C1-81FF-09928993F13E

P356

ONCOTARGET.8526

P1433

P1476

A combinational therapy of EGF ...... reast cancer brain metastases.

@en

P2093

Balveen Kaur

http://www.w3.org/2001/XMLSchema#string

Charlie Chen

http://www.w3.org/2001/XMLSchema#string

E Antonio Chiocca

http://www.w3.org/2001/XMLSchema#string

Hongwei Wang

http://www.w3.org/2001/XMLSchema#string

J Bradley Elder

http://www.w3.org/2001/XMLSchema#string

Jianfeng Han

http://www.w3.org/2001/XMLSchema#string

Jianhong Chu

http://www.w3.org/2001/XMLSchema#string

Jianhua Yu

http://www.w3.org/2001/XMLSchema#string

Jianying Zhang

http://www.w3.org/2001/XMLSchema#string

Lingling Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma

Prospective identification of tumorigenic breast cancer cells

Chimeric antigen receptor therapy for cancer

Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor

Stem cells, cancer, and cancer stem cells

Chimeric antigen receptor T cells for sustained remissions in leukemia

Cancer treatment and survivorship statistics, 2014

EGFR associated expression profiles vary with breast tumor subtype

CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.

A simple and sensitive method for measuring tumor-specific T cell cytotoxicity.

P304

27764-27777

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.8526

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27050072

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

5053686

http://www.w3.org/2001/XMLSchema#string